| <img alt="" height="1" width="1" />Ironwood Seeks 15% IPO Premium as Investors Lose in New DealsBusinessWeekThe proceeds will help fund the development of Ironwood's linaclotide drug, a treatment for irritable bowel syndrome and chronic constipation. ...Ironwood Gears Up for Biotech's Biggest IPO in Years, Sending Ripple Effect ...<nobr>Xconomy</nobr>5 IPOs planned for the week of Feb 1<nobr>Renaissance Capital</nobr><nobr>all 4 news articles »</nobr> |
Google- Ironwood Seeks 15% IPO Premium as Investors Lose in New Deals - BusinessWeek
1 - 1 of 1 Posts
1 - 1 of 1 Posts
- This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
Irritable Bowel Syndrome and Digestive Health Support Forum
A forum community dedicated to Irritable Bowel Syndrome and Digestive Health Support. Come join the discussion about treatment, diet, health, lifestyles, spirituality, medication, research, recovery, and more!
Full Forum Listing
Top Contributors this Month
View All
LifeLongIssues
11 Replies
secur.chiajna.fresh
10 Replies
work.yaninovenario
9 Replies
Recommended Communities
Join now to ask and comment!
